| BURU 0.3576 27.21% | CTNT 0.0329 -17.75% | TZA 5.245 4.07% | NOK 10.16 3.04% | SOXS 16.265 -3.18% | PAPL 1.05 74.88% | TSLL 11.85 -8.35% | QS 7.1934 -1.60% | INTC 66.945 2.57% | BITO 10.59 -2.13% | AUUD 5.25 35.66% | TSLA 371.18 -4.21% | AIXI 1.098 22.71% | NVDA 198.12 -2.16% | MEHA 0.1045 -18.99% | SOXL 109.0407 3.22% | BYND 1 -9.09% | MWYN 0.6383 12.18% | TQQQ 58.13 -3.45% | SMR 12.325 -9.17% | BMNG 1.4201 -13.41% | CGC 1.205 -12.68% | CPIX 3.87 26.89% | KEEL 3.195 5.10% | AAL 11.495 -0.04% | PLUG 3.0613 -4.03% | SPDN 9.2099 1.10% | SQQQ 56.645 3.50% | NVTS 17.9201 -2.98% | NVD 5.8014 4.34% | IREN 50.24 3.82% | APLD 35.185 8.50% | PLTR 140.668 -7.83% | POET 11.232 -12.04% | TLRY 7.0302 -10.67% | ONDS 10.185 -7.91% | YCBD 1.0629 14.29% | MSOS 4.39 -14.09% | SMCI 26.175 -10.30% | FFAI 0.3788 -10.49% | HIMS 27.33 -5.77% | SOFI 18.0302 -5.40% | MARA 11.6999 -1.18% | GRAB 3.9186 -3.48% | TRT 11.56 39.95% | PMEC 0.7475 6.59% | SPY 703.81 -1.04% | CMCSA 31.78 8.21% | AMD 301.5 -0.65% | MU 475.31 -2.50%

Market Bloodbath Alert: Top NASDAQ Losers Plunge Amid Volatility

In recent market movements, several companies have experienced significant price changes, impacting investors and stakeholders. Here's a consolidated analysis of the top losers, focusing on price movements, relevant events, and company developments.

- Mingteng International Corporation Inc. (NASDAQ: MTEN) sees a dramatic price drop of 76.72%, with its price plummeting to $0.14 from a year high of $26.03. This decline may be linked to market sentiment and company performance. Despite the downturn, Mingteng's Chairman and CEO, Mr. Yingkai Xu, emphasizes their strategic approach to managing market volatility and emerging trends, as highlighted by their unaudited financial results for the first half of fiscal year 2025.

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) faces a 49.90% drop in its price to $0.62. The company, involved in traditional Chinese medicine, launches a Strategic Artificial Intelligence (AI) Insights Initiative to optimize its portfolio and enhance market analysis. This move aims to address regulatory challenges and market competition, potentially impacting its future performance.

Veea Inc. experiences a 40.45% decrease in its price to $0.05. The company's focus on computing and cybersecurity solutions may face technological challenges and competitive dynamics in the IT services sector. These factors could contribute to its declining market position and investor confidence.

Aclarion, Inc. (NASDAQ: ACON) sees its price decrease by 39.75% to $4.92. Despite the drop, Aclarion reports a significant increase in Nociscan scan volumes and maintains a debt-free balance sheet with $12 million in cash. The company plans to enroll 25% of patients in the CLARITY trial by Q2 2026, with interim data expected in Q3 2026, indicating potential future growth.

These price movements highlight the volatile nature of the market and the various factors that can influence company valuations. Investors and stakeholders should closely monitor these companies for any further developments or announcements that could impact their positions.

Published on: January 9, 2026